Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - September, 2025
69 articles
- NY AG To Fight Texas Bid To Enforce Abortion Ban Ruling
- Oura Domestic Labor Investment Won Import Ban, ITC Says
- FisherBroyles Can't Nix Stem Cell Patent Malpractice Claim
- Whisper Not Enough To Sustain Worker's Harassment Suit
- How USPTO Examiner Memo Informs Software Patent Drafting
- Trump Returns To High Court In Foreign Aid Freeze Dispute
- FibroGen To Pay SEC $1.25M Over Drug Mistatements
- Catching Up With Delaware's Chancery Court
- 23andMe's Ch. 11 Sale Flouted State Privacy Law, Calif. Says
- DC Circ. Won't Halt Order Releasing Billions In Foreign Aid
- Stewart Tackles Markets, Injunctions In Newest PTAB Reviews
- Federal Agencies Push To Toss Masimo's Apple Watch Suit
- 2nd Circ. Backs Ex-Pfizer Worker's Insider Trading Conviction
- DOJ Pushes To DQ Attorney Over Conflict In Fraud Case
- Merck Shakes Off Some Claims From Cholesterol Drugs Suit
- Vein Tech Maker Wants Suit Over DOJ Kickback Probe Tossed
- FDA Explains Rejection Of MDMA Therapy For Treating PTSD
- Casper Can't Escape Innovator-Liability Drug Label Suit
- How 2nd Circ. Cannabis Ruling Upends NY Licensing
- Conn. Biotech Hits Ch. 11 With $2.7M Debt After Patent Suit
- Motley Rice Fights OptumRx DQ Bid In Utah Opioid Suit
- Parenting Skills That Can Help Lawyers Thrive Professionally
- Enablement Standard Insights From Fed. Circ. Agilent Ruling
- Feds Seek Stay On Court Order Releasing Foreign Aid Billions
- Split 3rd Circ. Rejects Janssen, Bristol Myers Pricing Appeal
- Doc Tells 1st Circ. Acquitted Conduct Marred Drug Sentence
- 4th Circ. Affirms Gardasil's Vaccine Table Inclusion
- Generic Drug Org Backs MSN In High Court Entresto Appeal
- GSK Adds Moderna's New COVID Vaccine To Del. IP Suit
- Why The Harvard Funding Case Is 'Clear As Mud' On Appeal
- Sterne Kessler Adds Ex-Deputy Chief PTAB Judge
- DOJ Moves To End Challenge To RFK Jr.'s Vaccine Directive
- Monthly Merger Review Snapshot
- Robitussin Maker Must Face Woman's Lung Infection Suit
- PBMs Look To Toss FTC's Insulin Pricing Case
- RFK Renews Attacks On CDC At Fiery Capitol Hill Appearance
- 3rd Circ. Preview: Sept. Features Biosimilars, Gambling Cases
- Teaching Trial Advocacy Makes Us Better Lawyers
- The Crucial Question Left Unanswered In EpicentRx Decision
- Sanofi Settles Conn. Zantac Suits Alleging Cancer Risks
- Purdue Pharma Approved For $17.5M In Ch. 11 Bonus Plans
- Ohio Cannabis Card Network Sued Over Faulty Cybersecurity
- 7th Circ. Backs AbbVie's Win Against Ex-Sales Rep's FCA Suit
- 9th Circ. Won't Revive Genentech Ex-Worker's 401(k) Suit
- Federal AI Action Plan Marks A Shift For Health And Bio Fields
- Fla. Surgeon General Pushes To End State's Vaccine Mandates
- Judge Backs Harvard In Suit Over Trump's $2B Fund Freeze
- Novartis Inks Up To $5.2B Deal With Chinese Cardio Biotech
- NC Panel Revives Biotech Co.'s Legal Malpractice Case
- Insurer Escapes Duty To Cover Lab's Suit Over COVID Tests
- Preparing For DEA Rescheduling Of 2 Research Chemicals
- Why EpicentRx Ruling Is A Major Win For Business Certainty
- Judge Accepts DNA Evidence In Gilgo Beach Case
- Auto Injection, Ypsomed Settle Insulin Pen Patent Dispute
- Speculation Can't Halt Medical Coatings Merger, GTCR Says
- $33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set
- Confusion Over Slashed Patent Verdict Vexes Fed. Circ. Judge
- Ex-Executive Slaps Novo Nordisk Unit With Sex, Age Bias Suit
- Jury Clears Exela In Blood Pressure Drug Patent Suit
- CooperSurgical Says Earlier Cases Sink Conn. Filshie Clip Suits
- Defective Vascular Port Caused Man's Death, Suit Says
- A Change In Big Pharma Response To FTC Delisting Warnings
- Gilead Rival Agrees Not To Sell Generic HIV Drug For Now
- Post-Ch. 11 Teligent 'Caremark' Suit Moves Forward In Del.
- As Product Recalls Rise, So Do The Stakes For The Bar
- Wells Fargo Employee Drug Cost Battle: What To Know
- Adapting To Private Practice: From Texas AUSA To BigLaw
- 'Never My Intention' To Defy Justices, Judge In NIH Case Says
- HHS Office Of Inspector General Leader Joins Arnold & Porter